Cargando…
Indoxyl Sulfate Promotes Arterial Thrombosis in Rat Model via Increased Levels of Complex TF/VII, PAI-1, Platelet Activation as Well as Decreased Contents of SIRT1 and SIRT3
Patients suffering from chronic kidney disease (CKD) are at a 20-fold higher risk of dying due to cardiovascular diseases (CVDs), primarily thrombosis following vascular injury. CKD is connected with retention of uremic toxins, especially indoxyl sulfate (IS), which are currently considered as a non...
Autores principales: | Karbowska, Malgorzata, Kaminski, Tomasz W., Znorko, Beata, Domaniewski, Tomasz, Misztal, Tomasz, Rusak, Tomasz, Pryczynicz, Anna, Guzinska-Ustymowicz, Katarzyna, Pawlak, Krystyna, Pawlak, Dariusz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6279869/ https://www.ncbi.nlm.nih.gov/pubmed/30546314 http://dx.doi.org/10.3389/fphys.2018.01623 |
Ejemplares similares
-
The Uremic Toxin Indoxyl Sulfate Accelerates Thrombotic Response after Vascular Injury in Animal Models
por: Karbowska, Malgorzata, et al.
Publicado: (2017) -
The impact of antihypertensive pharmacotherapy on interplay between protein-bound uremic toxin (indoxyl sulfate) and markers of inflammation in patients with chronic kidney disease
por: Kaminski, Tomasz W., et al.
Publicado: (2019) -
Indoxyl sulfate – the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease
por: Kamiński, Tomasz W., et al.
Publicado: (2017) -
Neurobehavioral effects of uremic toxin–indoxyl sulfate in the rat model
por: Karbowska, Malgorzata, et al.
Publicado: (2020) -
Simultaneous use of erythropoietin and LFM‐A13 as a new therapeutic approach for colorectal cancer
por: Tankiewicz‐Kwedlo, Anna, et al.
Publicado: (2018)